中西药联合治疗冠心病心绞痛的疗效观察

目的观察银丹心脑通软胶囊联合消心痛、倍他乐克治疗冠心病心绞痛的临床疗效。方法选择符合诊断标准的病例共80例,随机分为2组:对照组40例,给予单硝酸异山梨酯缓释片10～20mg,bid;倍他乐克5～10mg,qd;常规治疗;治疗组40例,在常规治疗基础上口服银丹心脑通软胶囊,每次2～4粒,tid,30d为1个疗程。结果治疗组心绞痛与心电图改善情况分别为87.5%和75%,对照组为62.5%和55%,2组比较差异均有显著性(P<0.05)。结论相对于常规治疗组,银丹心脑通软胶囊联合单硝酸异山梨酯缓释片、倍他乐克治疗冠心病心绞痛提高了疗效。

Efficacy Observation of Yindanxinnaotong Soft Capsules Combined with Isosorbide 5- mononitrate and Metoprolol Tartrate Tablet for Coronary Disease and Angina Pectoris

Objective To observe the therapeutic effect of Yindanxinnaotong Soft Capsules combined with two chemicals for coronary disease angina pectoris.Methods 80 cases which were up to the diagnosis standard were randomly divided into control group（n=40） and treatment group（n= 40）.Control groups were treated with the routine isosorbide 5-mononitrate sustained release tablets（10～20 mg,bid）,MetoprololTartrateTablets（12.5～ 25mg,qd）.Treatment group were additionally treated with 2 to 4 Yindanxinnaotong Soft Capsules,tid,p.o,with treating course of 30 days.Results The total efficacy rate of angina pectoris and the electrocardiogram were 80.85% and 74.47% for treatment group while 61.36% and 56.82% for control group.There was significant difference between two groups（P0.05）.Conclusion The therapeutic effect is improved by using Yindanxinnaotong Soft Capsules combined with isesorbide 5-mononitrate sustained release tablets,MetoprololTartrateTablets for coronary disease angina pectoris.